C6orf130 Antikörper (AA 51-150) (Biotin)

Produktnummer ABIN1701101

Produktdetails anti-C6orf130 Antikörper (Biotin)

Target: C6orf130 (OARD1) (O-Acyl-ADP-Ribose Deacylase 1 (OARD1))

Bindungsspezifität: AA 51-150

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser C6orf130 Antikörper ist konjugiert mit Biotin

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Homologie: Human,Mouse,Rat,Dog,Pig,Horse,Rabbit

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human C6orf130

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C for 12 months.

Haltbarkeit: 12 months

Details zu C6orf130

Target: C6orf130 (OARD1) (O-Acyl-ADP-Ribose Deacylase 1 (OARD1))

Andere Bezeichnung: C6orf130 (OARD1 Produkte)

Synonyme: C23H6orf130 antikoerper, C6orf130 antikoerper, TARG1 antikoerper, dJ34B21.3 antikoerper, AI314976 antikoerper, AW558560 antikoerper, O-acyl-ADP-ribose deacylase 1 antikoerper, OARD1 antikoerper, Oard1 antikoerper

Hintergrund:

Synonyms: C6orf130, OARD1_HUMAN, Chromosome 6 open reading frame 130, dJ34B21.3, O acetyl ADP ribose deacetylase C6orf130, Uncharacterized protein C6orf130.

Background: C6orf130 is a Making up nearly 6 % of the human genome, chromosome 6 contains around 1,200 genes within 170 million base pairs of sequence. Deletion of a portion of the q arm of chromosome 6 is associated with early onset intestinal cancer suggesting the presence of a cancer susceptibility locus. Porphyria cutanea tarda is associated with chromosome 6 through the HFE gene which, when mutated, predisposes an individual to developing this porphyria. Notably, the PARK2 gene, which is associated with Parkinson's disease, and the genes encoding the major histocompatiblity complex proteins, which are key molecular components of the immune system and determine predisposition to rheumatic diseases, are also located on chromosome 6. Stickler syndrome, 21-hydroxylase deficiency and maple syrup urine disease are also associated with genes on chromosome 6. A bipolar disorder susceptibility locus has been identified on the q arm of chromosome 6. The C6orf130 gene product has been provisionally designated C6orf130 pending further characterization.

Gen-ID: 221443